EdiGene Company

EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer.

Estimated Revenue: $10M to $50M
Funding Status: Early Stage Venture
Headquarters: China
Founded Date: 2015
Technology: Rare Genetic Disorders
Industry: Stem Cell Exhaustion